Nextcure Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nextcure company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nextcure Company Profile Today - Breaking & Trending Today

Marquette Asset Management LLC Invests $66,000 in NextCure, Inc. (NASDAQ:NXTC)

Marquette Asset Management LLC acquired a new stake in shares of NextCure, Inc. (NASDAQ:NXTC – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 58,259 shares of the company’s stock, valued at approximately $66,000. Separately, Acuitas Investments LLC raised its holdings in NextCure by 30.0% during the 4th quarter. Acuitas Investments LLC […] ....

Nextcure Company Profile , Needham Company , Acuitas Investments , Marquette Asset Management , Holdings Channel , Nextcure Inc , Free Report , Get Free Report , Visit Holdingschannel , Nextcure Daily , Nasdaq Nxtc , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

NextCure, Inc. (NASDAQ:NXTC) Short Interest Update

NextCure, Inc. (NASDAQ:NXTC – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 839,700 shares, a growth of 579.9% from the February 29th total of 123,500 shares. Based on an average trading volume of 229,500 shares, the short-interest ratio is […] ....

Silverarc Capital Management , Needham Company , Nextcure Company Profile , Tower Research Capital , Nextcure Inc , Jpmorgan Chase Co , Get Free Report , Capital Management , Street Corp , Research Capital , Nextcure Daily , Nasdaq Nxtc ,

HC Wainwright Boosts NextCure (NASDAQ:NXTC) Price Target to $8.00

NextCure (NASDAQ:NXTC – Free Report) had its price target boosted by HC Wainwright from $5.00 to $8.00 in a research note released on Friday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. Separately, Needham & Company LLC reissued a buy rating and issued a $4.00 target price on shares of NextCure […] ....

Cubist Systematic Strategies , Tower Research Capital , Needham Company , Jpmorgan Chase Co , Nextcure Company Profile , Nextcure Inc , Free Report , Systematic Strategies , Street Group , Research Capital , Get Free Report , Nextcure Daily ,

NextCure (NASDAQ:NXTC) Shares Down 1.1%

NextCure, Inc. (NASDAQ:NXTC – Get Free Report)’s stock price dropped 1.1% during trading on Monday . The stock traded as low as $1.30 and last traded at $1.34. Approximately 117,807 shares traded hands during trading, an increase of 79% from the average daily volume of 65,754 shares. The stock had previously closed at $1.35. NextCure […] ....

Nextcure Company Profile , Nextcure Inc , Cubist Systematic Strategies , Virtu Financial , Tower Research Capital , Get Free Report , Street Group , Systematic Strategies , Research Capital , Nextcure Daily , Nasdaq Nxtc ,

NextCure (NASDAQ:NXTC) Trading 0.9% Higher

NextCure, Inc. (NASDAQ:NXTC – Get Free Report)’s share price traded up 0.9% during trading on Monday . The company traded as high as $1.20 and last traded at $1.12. 124,661 shares traded hands during trading, an increase of 88% from the average session volume of 66,242 shares. The stock had previously closed at $1.11. Analyst […] ....

Needham Company , Nextcure Inc , Virtu Financial , Tower Research Capital , Nextcure Company Profile , Cubist Systematic Strategies , Get Free Report , Street Group , Systematic Strategies , Research Capital , Nextcure Daily , Nasdaq Nxtc ,